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Abstract Type 2 diabetes mellitus (T2DM) genetic testing is
undergoing clinical trials to measure the efficacy of genetic
counseling for behavior-based risk reduction. The expecta-
tions patients bring to the testing process may play an impor-
tant role in individual outcomes. We conducted a qualitative
exploration of anticipated decision-making and expectations
around T2DM genetic testing. Semi-structured interviews
were completed with Mexican Americans (n = 34), non-
Hispanic Black Americans (n = 39), and non-Hispanic
White Americans (n = 39) at risk for T2DM. Transcripts were
analyzed for themes. Most participants would accept T2DM
genetic testing in order to motivate risk-reducing behaviors or
apprise family members of their risk. Participants who would
decline testing wished to avoid emotional distress or believed
the test would not reveal new risk information. Non-Hispanic
Whites and those with college education declined genetic test-
ing more often than other groups. Those without college edu-
cation were more likely to have testing expectations that were
discordant with current science, such as conflating genetic
testing with common ‘blood tests.’ Understanding expecta-
tions and decision-making factors around T2DM genetic test-
ing will better prepare healthcare professionals to counsel their
patients. This may lead to a higher efficacy of T2DM genetic
testing and counseling.
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Qualitative research
The global burden of diabetes is responsible for more than
$612 billion in healthcare costs and a loss of over 34.6 million
years of life due to premature death per year (International
Diabetes Federation, 2013; WHO Department of Health
Statistics and Information Systems, 2013). Several clinical
trials have demonstrated that behavioral intervention can re-
duce the incidence of type 2 diabetes mellitus (T2DM;
reviewed in Schellenberg et al., 2013); however, large-scale
implementation has proven challenging across cultures and
within existing healthcare systems, resulting in minimal effect
on T2DM prevalence (Cardona-Morrell et al., 2010; Yates
et al., 2009). Thus, researchers continue to pursue new ways
of augmenting behavioral interventions and new methods of
targeting individuals at high risk for T2DM. Genetic testing
and genetic counseling for T2DM are being pursued in the
hopes that they may aid in the identification of individuals at
higher risk for T2DM and motivate risk-reducing lifestyle
modifications.
Several clinical trials (Centre d’Etudes et de Recherche
pour l’Intensification du Traitement du Diabète, 2012; David
Grant U.S. Air Force Medical Center, Duke University, 2013;
Proove Bioscience, Inc, 2015) and other studies have already
been initiated to measure the clinical value of T2DM genetic/
familial risk assessment and to develop best practices around
genetic counseling (Grant et al., 2009; Mills, Powell, Barry &
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Haga, 2015; Nishigaki et al., 2007; Nishigaki et al., 2011;
Nishigaki et al., 2014; Vassy et al., 2013; Voils et al., 2015).
To date, the results of these studies have been discouraging,
concluding that T2DM genetic testing as it currently exists is
not a promising clinical tool. Nevertheless, genetic medicine
is ever evolving. It is proper and necessary that research into
the human factor of genetic testing continue to advance even,
and preferably, ahead of the science of genetics itself. In this
qualitative paper, we will further explore T2DM genetic test-
ing and genetic counseling from the lay public’s perspective.
Our study will provide insight on the expectations, concerns,
and decision-making factors that patients may bring to an
initial genetic counseling and testing appointment. We impose
very little suggestion on our participants about what form
T2DM genetic testing may take. Instead, they supply their
own framework based on their own knowledge – a framework
which would serve as a starting point for any clinical encoun-
ter and thus one which may be of interest to clinicians.
T2DM, like other commonmultifactorial disorders, poses a
challenge to traditional genetic counseling paradigms (Becker
et al., 2011; O’Daniel, 2010; Wright & Kroese, 2009). There
are some commonalities between T2DM genetic testing and
genetic testing for rare Mendelian disorders. Both share three
major opportunities around which counseling could be incor-
porated: risk assessment, decision-making, and results disclo-
sure. Unlike rare Mendelian disorders, however, SNP-based
genetic testing for T2DM produces complex results that, at
this time, only modestly enhance risk assessment beyond tra-
ditional risk measures (the difference between a Bhigh^ phe-
notypic risk estimate and a combined Bhigh^ genetic plus
phenotypic risk estimate is approximately 6 %; Almgren et al.,
2011; deMiguel-Yanes et al., 2011;Meigs et al., 2008;Waxler
et al., 2012). In the case of T2DM genetic testing, the addi-
tional challenge to counselors and patients comes from grap-
pling with the paradox of complex-yet-limited genetic infor-
mation and the difficulty of weaving this discussion through-
out each of the three major counselling opportunities.
Because the clinical utility of T2DM genetic testing is
still under investigation, research on T2DM genetic testing
and counseling has been primarily outcome-oriented rather
than process-oriented. In other words, what limited re-
search exists has focused on psychological and behavioral
reactions to genetic results disclosure, rather than preced-
ing processes, such as decision-making. The only large-
scale clinical trials completed to date have failed to dem-
onstrate a statistically significant effect of T2DM genetic
testing and counseling on lifestyle modification (Grant
et al., 2013; Voils et al., 2015). Although several studies
using hypothetical scenarios initially raised the concern
that low T2DM genetic risk results would decrease pa-
tients’ motivation to improve lifestyle, (Grant et al.,
2009; Vassy et al., 2013; Vassy et al., 2012) neither pos-
itive nor negative differences in motivation or behaviors
have been detected among patients receiving high versus
low genetic risk results (Grant et al., 2013; Voils et al.,
2015).
Several factors may account for the apparent lack of utility
in T2DMgenetic testing and counseling. Although heritability
estimates suggest that T2DM genetic tests could be further
improved (Almgren et al., 2011), the difference between
Blow^ and Bhigh^ genetic risk results is currently less than
10 % (Waxler et al., 2012). Additionally, many potential con-
founders of the relationship between genetic risk results and
psychological and behavioral outcomes have yet to be consid-
ered (e.g., patients’ decision-making process and expectations
about genetic testing; Klitzman, 2010). Thus, it is important to
take a step back and examine the public’s preconceptions
about T2DM genetic testing in order to identify other factors
that may play into the efficacy of the test and to better prepare
clinicians to support their patients throughout the testing and
counseling process.
As a first step towards this goal, we conducted an explor-
atory qualitative study of anticipated genetic testing decision-
making among individuals at risk for T2DM using hypothet-
ical scenarios. We also only included individuals who indicat-
ed in a previous structured interview that they believed in a
genetic contribution to their risk for T2DM. Based on feed-
back from interview pretesting, we determined that partici-
pants who did not already believe in a genetic contribution
to their T2DM would be unable to suspend their disbelief and
would have thus been unable to respond to the hypothetical
scenario. Because the health burden of T2DM is unequally
distributed across race/ethnicity (American Diabetes
Association [ADA], 2015; U.S. Department of Health and
Human Services, 2008), we examined three U.S. subpopula-
tions: Mexican Americans, non-Hispanic Blacks, and non-
Hispanic Whites. Participants were asked to decide whether
they would choose to have genetic testing related to T2DM
and then prompted to explain their decision. Themes around
decision-making and testing expectations were evaluated in
light of demographic background and participants’ prior risk
perceptions.
Methods
Participants
The Genetic Explanations for Type 2 Diabetes: Prevention
Implications (GEDI) project is a national, landline telephone
survey of non-diabetic Mexican Americans, non-Hispanic
Blacks, and non-Hispanic Whites aged 18 to 75 who live in
the contiguous U.S. GEDI used mixed quantitative and qual-
itative methodology. Phase I of GEDI employed a structured
survey (conducted August 2011 through February 2012). In
Phase II, a subset of Phase I participants were recontacted to
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complete a semi-structured qualitative interview (conducted
February through April 2012). This paper primarily discusses
data from Phase II. The study was approved by the University
o f M i ch i g an ’s I n s t i t u t i on a l Rev i ew Boa rd ( #
HUM00058581). Oral informed consent was obtained from
all participants.
Phase I participants were recruited using randomly gener-
ated landline numbers (Marketing Systems Group). During
Phase I, self-reported risk factors for T2DM and beliefs about
the causes of T2DM were assessed. Phase I participants
(N = 1168) were then purposively sampled for recruitment
into Phase II (n = 112) based on two eligibility criteria: (1)
at-risk status for T2DM and (2) their belief that their personal
genetics influenced their risk for developing T2DM (in order
to avoid problematic failure to suspend disbelief, as described
in the Introduction). At Phase I, genetic beliefs were assessed
by asking BIn your opinion, do your genes increase, decrease,
or have no influence on your chance of getting type 2
diabetes?^ Those who believed their genes had no influence
were ineligible for Phase II. Overall, 475 Phase I participants
(41 %) met Phase II eligibility criteria; two hundred twenty-
five Phase I telephone lines were released for Phase II
recruitment.
Participants who reported prediabetic status or having
received high-risk warning from their physicians were con-
sidered at-risk for T2DM. To determine at-risk status for
participants without prediabetes or a physician’s warning,
self-reported risk factors were compared to a subset of
ADA screening criteria (ADA, 2015). Participants were
classified as at-risk if they were overweight (BMI ≥ 25)
and had at least one other risk factor: severe obesity
(BMI ≥ 35), physical inactivity (U.S. Department of
Health and Human Services, 2008), a first-degree relative
with diabetes, a history of gestational diabetes, high blood
pressure, high cholesterol, heart disease, or self-
identification with a high-risk race/ethnicity (non-Hispanic
Black or Mexican American).
Interviews
Telephone interviews (M = 26.5 min; SD = 7.87 min) were
conducted by six professional interviewers from the
University of Michigan Institute for Social Research. Five of
the interviewers were women and one was a man. One inter-
viewer identified as non-Hispanic Black, while the other five
identified as non-Hispanic White. Two interviewers were bi-
lingual Spanish/English speakers. Interviewer education
ranged from Associates through Bachelor’s degrees from a
variety of fields. All interviewers were trained under the
Institute for Social Research’s General Interviewing
Technique program and received study-specific training,
which included instruction and certification in the use of
computer-aided telephonic interviewing tools, demeanor,
and open-ended interview techniques. All interviewers com-
pleted mock interviews during training, with periodic quality
checks during data collection.
This paper analyzes responses to the following interview
questions:
Suppose there was a test to see if your genes increase your
chance of getting type 2 diabetes.
1 Would you want to get tested?
2 Why would you (not) want to get tested? / Are there any
reasons why you would (not) want to get tested?
In order to identify decision-making factors originating
from the participants themselves, they were not provided in-
formation about the sensitivity or the risks/benefits of testing.
In order to further explore their decision-making process, par-
ticipants who focused only on barriers to genetic testing, such
as a fear of needles, were probed to explain what their decision
would be if such barriers did not exist.
Data Analysis
NVivo (version 10; QSR International, MA, USA) was used
for transcript coding. Stata (version 12; StataCorp LP, TX,
USA) was used to calculate descriptive statistics of demo-
graphic data, frequencies of themes, and inter-coder reliability.
Due to a scarcity of literature on perceptions about genetic
testing related to T2DM, transcribed interviews were analyzed
through conventional content analysis using inductive code
generation as described by Hsieh and Shannon (2005). An
inductive, data-driven codebook was developed through an
iterative process of open-coding and code refinement until
theoretical saturation was achieved (MacQueen et al., 1998).
All authors and coders participated in the iterative code devel-
opment process. Coders received training in qualitative
methods from authors A.G.C, T.E.J., and B.M.Y., including
a review of qualitative literature and practice coding sessions.
Codebook training and practice coding continued until an
overall Cohen’s kappa of 0.7 was reached. The value 0.7
was chosen a priori as a conservative measure of inter-coder
reliability within the context of exploratory research
(Lombard et al., 2002). Each transcript was then independent-
ly coded by two coders drawn from a team of four (including
E.J.M. and B.B.H.). Inter-coder reliability was continually
assessed throughout the coding process to ensure coding con-
sistency was maintained, with periodic codebook review ses-
sions. All coders were non-Hispanic White women. Two
coders were Master’s students, one of whom was studying
Genetic Counseling and the other was studying Health
Behavior and Health Education. The other two coders were
Bachelor’s students, one of whom was studying Genetics and
Ethics and the other was studying Psychology. All transcripts
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were reviewed by at least one Master’s student. Coders re-
solved coding disagreements through discussion.
Results
Demographics, risk perceptions, and secondary T2DM risk
factors for the 112 participants are presented in Table 1.
Unsurprisingly, due to the ADA risk factor inclusion criteria,
the most common T2DM risk factor reported by all subsam-
ples was being overweight (BMI ≥ 25). Mean BMI was sim-
ilar among Mexican American (M = 30.8, SD = 5.87), Black
(M = 32.3, SD = 6.79), and White (M = 31.2, SD = 5.22)
participants. Excluding race/ethnicity, the most frequently re-
ported secondary risk factor for T2DM was family history
amongMexican Americans (38 % of participants), high blood
pressure among non-Hispanic Blacks (56 %), and physical
inactivity and high blood pressure among non-Hispanic
Whites (both 49 %). Despite these self-reported T2DM risk
factors, 44 % of all participants believed their risk was low.
Anticipated Genetic Testing Decision
Overall, most participants (n = 91) anticipated utilizing a
T2DM genetic test if one were offered to them. Amuch small-
er portion (n = 18) would decline. Very few participants
(n = 2) were unable to make a final decision. No testing deci-
sion could be determined for one participant due to interview-
er error. Importantly, participants with high-perceived risk for
T2DMwere more likely to reject genetic testing (n = 7, 23 %)
than those with average (n = 3, 9 %) or low (n = 8, 16 %) risk
perceptions. Non-Hispanic White participants rejected testing
more frequently (n = 8, 21%) thanMexican Americans (n = 4,
11 %) or non-Hispanic Blacks (n = 6, 15 %). Participants with
college education anticipated declining genetic testing more
frequently (n = 16, 20%) than those with less education (n = 2,
7 %). Statistical testing is inappropriate given our qualitative
design, and the intention of this study is neither to establish
definitive group differences nor to generalize our conclusions
to the wider U.S. population. The data suggest, however, a
potential pattern between education, race/ethnicity, and
Table 1 Demographics, risk perception, and risk factors by race/ethnicity, n (%)
Characteristic Mexican Americans
(n = 34)
Non-Hispanic Blacks
(n = 39)
Non-Hispanic Whites
(n = 39)
Gender
Women 17 (50) 21 (54) 20 (51)
Men 17 (50) 18 (46) 19 (49)
Age
18–44 20 (59) 12 (31) 11 (28)
45–60 11 (32) 17 (44) 14 (36)
61–75 3 (9) 10 (26) 14 (36)
Education
No college 11 (32) 11 (28) 8 (21)
College 23 (68) 28 (72) 31 (79)
Annual income
≤ $25,000 4 (12) 7 (18) 7 (18)
$25,001 - $50,000 15 (44) 12 (31) 6 (15)
$50,001 - $85,000 7 (21) 9 (23) 6 (15)
> $85,000 6 (18) 10 (26) 16 (41)
Perceived T2DM risk
Low 18 (53) 13 (33) 18 (46)
Average 8 (24) 14 (36) 10 (26)
High 8 (24) 12 (31) 11 (28)
Secondary T2DM risk factors
First-degree relative with diabetes 13 (38) 17 (44) 13 (33)
Heart disease 0 (0) 3 (8) 6 (15)
High blood pressure 9 (27) 22 (56) 19 (49)
High cholesterol 10 (29) 17 (44) 16 (41)
Physical inactivity 11 (32) 13 (33) 19 (49)
Severe obesity 6 (19) 13 (33) 7 (18)
Percentages may not sum to 100 due to rounding or exclusion of missing data
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anticipated testing decisions (Table 2). Among non-Hispanic
Blacks and Whites, but not among Mexican Americans, those
with college education tended to have decreased interest in
genetic testing.
Theme Development and Concordance Analysis
Codes were collapsed into higher-level themes organized
around two related topics, elements of the decision-making
process and genetic testing expectations. Three major themes
emerged from participant’s decision-making explanations:
Information Orientation, Barriers to Testing, and Relevancy
Based on Age. By Borientation^ we mean attitudes towards
genetic information. Information Orientation was by far the
most frequent and rich overarching theme, warranting further
segmentation based on participants’ level of interest or ambiv-
alence towards the content of genetic test results, as follows:
Information-Seeking, Information-Avoiding, and
Information-Neutral. We use the term Bbarrier^ broadly to
mean all things peripheral to the genetic test result itself,
whether physical or psychological, which would prevent an
individual from obtaining an otherwise desirable test.
Participants’ expectations around genetic testing were
also summarized by three major themes: Testing
Procedure, Knowledge about Genetics, and Content of
Test Results. Participants’ expectations were compared
with existing T2DM genetic counseling protocols
(Grant et al., 2013; Waxler et al., 2012). Expectations
were categorized as concordant with that of genetics
professionals if they aligned with the following informa-
tion, and were categorized as discordant if they did not:
& [Testing Procedure] Genetic testing procedures are typi-
cally minimally invasive and low-risk, including blood
draws, blood spots, cheek scrapes, or saliva samples.
& [Knowledge about Genetics] While genetic tests may be
refined, the underlying genetic information is permanent
and does not change across the life course.
& [Knowledge about Genetics] Genetic variants do not
Bskip^ generations.
& [Content of Test Results] Genetic test results related to
T2DM provide information based exclusively on genes.
Some researchers have attempted to combine genetic and
lifestyle risk factors for a more holistic, individualized risk
report (Almgren et al., 2011; deMiguel-Yanes et al., 2011;
Grant et al., 2013; Meigs et al., 2008; Waxler et al., 2012),
but methods for the combination of these results have not
yet been fully developed.
& [Content of Test Results] T2DM-related genetic informa-
tion is predictive and not diagnostic.
Concordance and discordance were not treated as binary
opposites. Therefore, percent concordance and percent discor-
dance will not sum to 100. A single participant could demon-
strate concordance, discordance, both, or, if there was insuffi-
cient evidence, neither concordance nor discordance.
Participants whose responses provided insufficient evidence
for concordance or discordance tended to be terse or vague
despite probing and encouragement from the interviewer. For
example,
Interviewer:If you did get tested, what do you think your
test results might show?
Respondent:I have no idea.
Interviewer:What do you think? Given on what you told
me about–what we’ve talked about so far, what do you
think your test results might show?
Respondent:It may show more than I have an idea.
Elements of the Decision Making Process
Participants were asked to explain both their reasons against
and in favor of T2DM genetic testing. These themes and their
subthemes are summarized below. Illustrative quotations are
presented in Table 3.
Table 2 Relationships between race/ethnicity and education among themes
Race/Ethnicity Education (n) Testing decision n (%) Concordant statements n (%) Discordant statements n (%)
Yes No
Mexican American No College (11) 10 (91) 1 (9) 6 (55) 8 (73)
College (23) 20 (87) 3 (13) 17 (74) 7 (30)
Non-Hispanic Black No College (11) 11 (100) 0 (0) 4 (36) 8 (73)
College (28) 22 (79) 6 (21) 22 (79) 9 (32)
Non-Hispanic White No College (8) 7 (88) 1 (13) 6 (75) 3 (38)
College (31) 21 (68) 7 (23) 22 (73) 6 (20)
Percentagesmay not sum to 100 due to rounding or exclusion ofmissing data. Two participants’ testing decisions were classified as BMaybe – neither yes
nor no.^ No testing decision was given by one non-Hispanic White, college-educated participant due to interviewer error. These participants’ data are
omitted from testing decision
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Information Orientation (n = 88) Participants’ orientation
toward the information provided by genetic testing was central
to most decision-making explanations. Information
Orientation included three subthemes: Information-Seeking
(n = 75), Information-Avoiding (n = 16), and Information-
Neutral (n = 14). Some information-seeking participants be-
lieved that collecting their genetic information was good for
its own sake (n = 12, 16 %), but most (n = 63, 84 %) desig-
nated at least one practical application for their test results: to
identify risk-reduction strategies, increase motivation to take
action, to raise awareness of T2DM risk among their family
members, and/or to diagnose T2DM. Information-avoiding
participants believed the test results could provoke psycholog-
ical burdens such as unwanted pressure to change one’s life-
style and stress over the potential for disease. Information-
neutral participants described T2DM genetic testing as
providing no added value because of the impossibility of mod-
ifying genetic risk factors directly or because they were al-
ready aware of their phenotypic or family history-based risk
status.
Barriers to Testing (n = 21) Examples of barriers to testing
included the expense of the test, unpleasant testing process,
and lack of confidentiality. Participants explained that a high-
cost test, particularly one not covered by insurance, would be
a luxury when weighed against more immediate needs.
Concern about an unpleasant testing process ranged from fear
that the test would involve a dangerous or extremely painful
medical procedure, to the common phobia of needles, to the
more mild worry that the testing process would be Ba hassle.^
Participants who discussed confidentiality worried that
Table 3 Themes and subthemes with representative quotations
Theme Quotations
Elements of the decision-making process
Information-seeking Sometimes when it’s four o’clock and I’m exhausted
and I don’t want to go to the gym—that [my genetic risk]
might be one more reason in the back of my head that
I do make that effort to go.
Information-avoiding I’m not ready to go ahead and switch over to eating that healthy. And I feel like if I know that [I have genetic risk], then I’ll
be bound
by eating proper the whole time and I–I really just gotta get right.
Information-neutral I mean I know my family history, I know what I need to do, I know
what could possibly put me at greater risk. Therefore, no,
I don’t need to be tested.
Barriers to testing You got a $6000 bill just from going to get tested and you don’t
even have money to buy groceries.
Relevancy based on age I’d personally probably wouldn’t simply because of my age…
I’ve kind of become set in my ways.
Genetic testing expectations
Content of test results Discordant: It’s [the test is] gonna show you if you have the
diabetes or the risk.…Maybe it’s going to show me how my
cholesterol is in the moment, my ascorbic acid, my blood,
my white cells and my red cells in my body, in my blood.
Concordant: I mean you’re not just talking about lab results that
looking at how well your body is functioning. You’re not
talking about it–you’re talking about genes specifically, right?
Knowledge about
genetics
Discordant: They say it [the gene] skips a generation, but I know
it didn’t with my brother. My mother has it [diabetes].
Concordant: Well because–one thing is because I can’t change
that part of it [genetic risk]. If you know the things that predispose you,
if you know that and if you’re willing to work to minimize–some things
you’re never going to be able to change.
Testing procedure Discordant: I don’t know how they do the test. But if it was some test that was
dangerous where they had to open you up and take your heart out and take blood
out of the heart or something and sew you back up, then I would probably think
harder about it.
But if they just had to take a blood test and then I would see no problem.
Concordant: […] I guess if there was a free [genetic] test at a clinic and they
pricked my blood,
you know what I mean, if it was a simple thing to just go do.
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insurers would discriminate against them based on their test
results.
Relevancy Based on Age (n = 10) Some participants indicat-
ed that the decision to test should be based on one’s age. The
definition of Bright^ versus Bwrong^ age varied and was de-
scribed with respect to life stage or relative to the participant’s
own age. The concept of Bright age^ was tied to the belief that
this was an age at which (1) health habits were still malleable,
(2) preventive actions were still likely to be effective, and/or
(3) risk for T2DM was increasing.
Genetic Testing Expectations
In justifying their anticipated testing decisions, participants
discussed their expectations about the test. As described in
Methods, these expectations centered around three major
themes and were further categorized as concordant or discor-
dant with the standard medical procedures. While most cases
could be coded as containing concordant and/or discordant
statements (n = 99), some responses were unclassifiable
(n = 13) due to either ambiguity or absence of content.
Content of Test Results (n = 87)Most of the participants who
discussed the content of their test results made concordant
statements (n = 64, 74 % of cases), such as expecting the test
to provide risk information, understanding the exclusively ge-
netic nature of the test, and believing in the stability of their
genetic information. Discordant expectations around the con-
tent of test results were generally subtle. Over a third (n = 35,
40 %) of participants who discussed the content of their test
results conflated genetic test results with routine Bblood tests^
related to T2DM risk (e.g., lipid panels, fasting plasma glu-
cose screening), believed the genetic test results would in
some way account for current physical and dietary behaviors,
or believed the test would be diagnostic rather than predictive.
Knowledge about Genetics (n = 54) Participants’ genetic
beliefs were more often concordant with genetics profes-
sionals (n = 41, 37 %) than discordant (n = 15, 13 %).
Participants demonstrating concordant genetic beliefs
discussed, for example, the link between their test results
and inherited risk factors faced by family members.
Participants demonstrating discordant genetic beliefs antici-
pated that their test results might change over time. Others
discussed Bskipped generation^ inheritance patterns, which,
if conceived of as originating in the genotype, are common
misconceptions arising when diseases exhibit X-linked inher-
itance, imprinting, or reduced penetrance (Klitzman, 2010;
Tessaro et al., 2005).
Testing Procedure (n = 6) All participants (n = 6) who
discussed the genetic testing process made at least one
statement suggesting an understanding of the genetic testing
process that was concordant with actual medical protocols;
however, three of these participants were also uncertain about
the testing process and believed the test was at least potentially
invasive or dangerous.
Relationship between Anticipated Decisions, Decision
Making Factors, Genetic Testing Expectations,
and Background Factors
Decision-making themes varied by testing decision, educa-
tion, race/ethnicity, and perceived risk (Table 4).
Unsurprisingly, those who anticipated declining genetic test-
ing, and those with characteristics suggested to be associated
with declining genetic testing (college education, non-
Hispanic White identity, high perceived risk), tended to focus
on Information-Neutrality and Information-Avoiding sub-
themes, rather than Information-Seeking. Non-Hispanic
Whites also cited Barriers to Testing more often than
Mexican American or non-Hispanic Black participants,
though these barriers tended to be psychological rather than
physical or financial in nature. Similar to the pattern observed
between race/ethnicity, education, and anticipated testing de-
cision, the data suggest a potential relationship between con-
cordance, discordance, and education, and race/ethnicity
(Table 2). While those with higher education tended to have
a higher frequency of concordant statements overall, there was
virtually no difference in the frequency of concordant state-
ments between non-Hispanic Whites with and without a col-
lege education.
Discussion
We interviewed 112 Mexican Americans, non-Hispanic
Blacks, and non-Hispanic Whites who had significant risk
factors for T2DM about their desire for a hypothetical genetic
test related to T2DM. Our qualitative analysis revealed find-
ings that reinforce and augment existing research in several
ways. In agreement with previous research (Grant et al., 2009;
Haga et al., 2013; Markowitz et al., 2011), the vast majority of
our participants believed they would accept genetic testing for
T2DM risk if it was offered to them.We further identified two
potential decision-making trends: (1) those who identified as
non-Hispanic White and (2) those with college-level educa-
tion (except Mexican Americans) were more likely to reject or
feel hesitant about T2DM genetic testing compared to other
groups.
The purpose of this qualitative research was exploratory; it
was not designed to support statistical comparisons. Further
investigation in a representative national sample is necessary
to investigate potential group differences or interactions. If the
trends we observed were to be confirmed, our qualitative
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analysis suggests potential explanations for lower interest in
T2DM genetic testing among college-educated and non-
Hispanic White participants that ought also to be studied. In
line with previous research on genetic literacy and education
(Christensen et al., 2010; Haga et al., 2013; Lea et al., 2011),
college-educated and non-Hispanic White participants were
more likely to have expectations for testing that were concor-
dant with current medical science and more frequently
expressed concerns or doubts about genetic testing. Taken
together, these findings raise important questions that have
implications for both health behavior outcomes and tailored
patient education. Are patients with higher education more
skeptical about the value of T2DM genetic testing because
they have a greater understanding for the drawbacks and lim-
itations of genetic testing for complex diseases? Does it follow
that historical disparities in education underlie racial/ethnic
differences in interest and decision-making processes around
T2DM genetic testing? No claims can be made in this study,
but these questions deserve further investigation.
Implications for Tailored Patient Education
Consistent with previous research on genetic literacy
(Christensen et al., 2010; Lanie et al., 2004), this study iden-
tified several misconceptions about genetic testing that are
relevant to patient education and genetic literacy outreach.
Participants expressed uncertainty about genetic inheritance,
the invasiveness of genetic testing, and the predictive (rather
than diagnostic) nature of T2DM genetic test results. Of note,
we found that the context of T2DM provides unique opportu-
nities for miscommunication between patients and clinicians
about genetic testing. Participants in this study were familiar
with routine Bdiabetes blood tests^ (referring to hemoglobin
A1c tests or similar). Despite having distinctive purposes,
benefits, and risks, routine diabetes testing was sometimes
conflated with T2DM genetic testing because both fall into
the broad category Bblood test.^ If T2DM genetic testing were
to become available to the general public, healthcare providers
would be prudent to take special care disentanglingmore com-
mon Bdiabetes blood tests^ from T2DM genetic testing during
patient counseling and education.
This study suggests, however, that higher education and
higher genetic literacy may actually decrease interest in
T2DM genetic testing. While more research is needed, our
analysis indicates that individuals with higher education and
higher genetic literacy may have a healthy skepticism of the
value that genetic testing would add beyond conventional
T2DM risk assessments and may be more sensitive to poten-
tial harms, such as genetic discrimination. Our findings are in
agreement with prior research in which participants with
higher genetic knowledge were more likely to perceive
DNA testing as Bfrightening^ (Haga et al., 2013). Thus,
achieving high genetic literacy should not be the only goal
of patient education and counseling. Raising genetic literacy
may facilitate weightier conversations between patients and
their healthcare providers on the nature of T2DM genetic
Table 4 Frequency of decision-making themes and subthemes by participant characteristics, n (%)
Characteristic (n) Themes and subthemes
Information orientation Barriers to testing Relevancy based
on age
Seeking Neutral Avoiding
Anticipated testing decision
Yes (91) 69 (76) 3 (3) 9 (10) 17 (19) 5 (5)
No (18) 3 (17) 10 (56) 5 (28) 3 (17) 5 (28)
Education
No College (30) 19 (66) 1 (3) 1 (3) 5 (17) 3 (10)
College (82) 55 (67) 13 (16) 15 (18) 16 (20) 7 (9)
Race/ethnicity
Mexican American (34) 24 (71) 3 (9) 3 (9) 4 (12) 3 (9)
Non-Hispanic Black (39) 29 (74) 5 (13) 4 (10) 7 (18) 2 (5)
Non-Hispanic White (39) 22 (55) 6 (15) 9 (23) 11 (28) 5 (13)
Perceived T2DM Risk
Low (49) 30 (61) 4 (8) 7 (14) 8 (16) 6 (12)
Average (32) 23 (70) 3 (9) 2 (6) 9 (27) 2 (6)
High (31) 22 (71) 7 (23) 7 (23) 5 (16) 2 (6)
Percentagesmay not sum to 100 due to rounding or exclusion ofmissing data. Two participants’ testing decisions were classified as BMaybe – neither yes
nor no.^ No testing decision was given by one non-Hispanic White, college-educated participant due to interviewer error. These participants’ data are
omitted from anticipated testing decision
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information but may only be the first step toward more in-
formed decision-making around genetic testing.
Implications for Health Behavior Outcomes
The majority of participants’ decision-making centered on
their orientation to genetic information (Information-
Seeking, Information-Avoiding, or Information-Neutral).
Individuals who demonstrated the Information-Seeking theme
believed their T2DM genetic test results would motivate them
to decrease their personal risk for T2DM (or that of their
family members) through lifestyle modification. Research
has demonstrated a gulf between intention to change health
behaviors and actual behavioral change (Webb & Sheeran,
2006), and early clinical trials have failed to demonstrate be-
havioral benefits from T2DM genetic testing in its current
limited form (Grant et al., 2013; Voils et al., 2015).
Nevertheless, T2DM genetic testing may be beneficial to in-
dividuals who are already on the precipice of lifestyle change.
In contrast to Information-Seeking participants, Information-
Avoiding participants’ decision-making process focused on
reducing stress, fear, and anxiety over T2DM risk by declining
genetic testing. When asked directly, some of these individ-
uals admitted that they already perceived themselves to be at
high risk for T2DM, but they also acknowledged that they did
not feel ready to make lifestyle changes.
The difference between Information-Seekers and
Information-Avoiders may lie in individuals’ strategies of cop-
ing with stressful experiences (McAndrew et al., 2008).
Information-Seeking participants appeared to employ
objective-oriented strategies of coping with hypothetical ge-
netic risk (e.g., reducing risk through action), whereas
Information-Avoiding participants seemed to rely on psycho-
logical coping strategies directed toward regulating their emo-
tional reactions to risk (e.g., denial, avoidance). Thus, inter-
ventions that focus first on enhancing positive emotional reg-
ulation, such as those derived from Leventhal’s Common
Sense Model of Self-regulation (Cameron & Jago, 2008),
may help promote healthy behavior changes among those ex-
pressing Information-Avoidance toward T2DM genetic
testing.
A third distinct group, Information-Neutral participants,
saw neither benefit nor harm in T2DM genetic testing.
These individuals did not afford any special value to genetic
information above other modes of T2DM risk assessment.
Thus, most Information-Neutral participants anticipated they
would decline genetic testing, and thus their genetic status
would have no effect on their behavior.
Strengths and Limitations
The exploratory approach and purposive sampling in our
study limits the generalizability of results and precludes
statistical hypothesis testing. Because this study used a hypo-
thetical scenario, participants’ anticipated uptake of T2DM
genetic testing likely overestimates what the level of uptake
would be in a real clinical environment (Persky et al., 2007).
Additionally, this study was limited to participants who be-
lieved that their genes either increased or decreased their per-
sonal risk of T2DM, rather than individuals who believed in a
genetic contribution to T2DM in general. Therefore, individ-
uals less open to a genetic contribution to T2DM are under-
represented. Similarly, those who believe genes play a role in
T2DM, but do not contribute directly to their own T2DM risk,
are underrepresented; however, it is unclear if there would be
differences in the interpretation of the interview question by
this group of people. Nevertheless, the decision-making pro-
cess and genetic testing expectations expressed by participants
are still highly relevant to pre-test counseling and education.
A number of our findings have importance for future re-
search. First, it is unclear why the trends pertaining to educa-
tion and interest in genetic testing were only observed in some
races/ethnicities; given the qualitative nature of our study, it is
inappropriate to draw conclusions from this data. Our findings
are of potential interest, however, for hypothesis generation
and suggest that hypothesis-based statistical testing in a larger,
representative sample may be warranted. Second, although all
participants were classified as high-risk for T2DM based on
phenotype, 44 % (n = 49) of them perceived their risk to be
Blow.^ It is unclear whether the combination of phenotypic
high risk for T2DM with low risk perception is atypical of the
populations sampled. It is possible, though not tested here, that
skewed risk perceptions are commonplace. Alternatively, par-
ticipants were classified as at-risk for T2DM based on self-
reported risk factors, rather than medical records. It is unclear
whether this procedure over- or underestimated participants’
true T2DM risk level (Kuczmarski et al., 2001), an important
question for further study.
Finally, we note two important strengths of our research: 1)
The exploratory nature of this study allowed participants to
volunteer those aspects of T2DM genetic testing that were
most meaningful to them, rather than limiting the investiga-
tion to predetermined concepts drawn from theory; 2) The
inclusion of a large number of participants from diverse de-
mographic backgrounds is a significant addition to the litera-
ture, and suggests the need for formally testing group differ-
ences using quantitative methods in diverse samples.
Conclusions
T2DM genetic testing is in its infancy. This study identified
factors in the decision-making process and genetic testing ex-
pectations that patients from varied backgrounds are likely to
bring to such testing protocols. Our findings serve as a foun-
dation to inform genetic counseling and future research on the
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efficacy of T2DM genetic testing. In particular, this study calls
for investigation of the effects of educational attainment and
racial/ethnic background factors on perceptions about T2DM
genetic testing and identifies common misconceptions about
the testing process.
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